Efficacy and Safety of Facilitated Subcutaneous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Disease: Interim Analysis of a Phase 3 Study in the USA
JOURNAL OF CLINICAL IMMUNOLOGY（2022）
Key words
Facilitated subcutaneous immunoglobulin, Immunoglobulin replacement therapy, Primary immunodeficiency disease, Pediatric, Efficacy, Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined